৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Indications: Rosuvastatin is indicated for patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated Total‑C, LDL‑C, ApoB, non‑HDL‑C, and triglycerides, and to increase HDL‑C. It is also indicated for patients with hypertriglyceridemia, primary dysbetalipoproteinemia (Type III), and homozygous familial hypercholesterolemia (HoFH) to reduce LDL‑C, Total‑C, and ApoB. Rosuvastatin helps slow the progression of atherosclerosis as part of a treatment strategy to lower Total‑C and LDL‑C. In pediatric patients aged 10–17 years with heterozygous familial hypercholesterolemia (HeFH), it reduces elevated Total‑C, LDL‑C, and ApoB after an adequate trial of diet therapy. Additionally, it reduces the risk of myocardial infarction, stroke, and arterial revascularization procedures in patients without clinically evident coronary heart disease but with multiple risk factors.
Pharmacology: Rosuvastatin is a selective and competitive inhibitor of HMG‑CoA reductase, the rate‑limiting enzyme that converts 3‑hydroxy‑3‑methyl‑glutaryl‑CoA to mevalonate, a precursor of cholesterol. It produces lipid‑modifying effects by increasing hepatic LDL receptors to enhance LDL uptake and catabolism, and by inhibiting hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.
Dosage & Administration: For pediatric patients (10–17 years, HeFH), the usual dose is 5–20 mg/day, with a maximum of 20 mg/day. For very high cholesterol or high risk of MI/stroke, 40 mg once daily is recommended. In HoFH, the starting dose is 20 mg once daily. For Asian patients, initiation with 5 mg once daily should be considered. With cyclosporine, the dose should be limited to 5 mg/day; with lopinavir/ritonavir or atazanavir/ritonavir, limited to 10 mg/day. Combination with niacin or fenofibrate may increase muscle risk, so dose reduction should be considered. Combination with gemfibrozil should be avoided; if necessary, limit to 10 mg/day. In severe renal impairment, start with 5 mg/day and do not exceed 10 mg/day.
Drug Interactions: Cyclosporine increases exposure; dose limited to 5 mg/day. Gemfibrozil should be avoided; if used, limit to 10 mg/day. Lopinavir/ritonavir or atazanavir/ritonavir increase exposure; limit to 10 mg/day. Coumarin anticoagulants may prolong INR; monitor until stable. Fibrates and niacin may increase risk of muscle effects.
Contraindications: Rosuvastatin is contraindicated in patients with hypersensitivity to product components, active liver disease including unexplained persistent elevations of hepatic transaminases, pregnant women, and nursing mothers.
Side Effects: Rosuvastatin is generally well tolerated. The most common adverse effects include headache, myalgia, constipation, asthenia, abdominal pain, and nausea.
Drug Class: Statin (HMG-CoA reductase inhibitor)
Purpose: Used to lower cholesterol and triglycerides in the blood, thereby reducing the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism: Blocks the enzyme HMG-CoA reductase in the liver, reducing cholesterol production.
Benefits:
Lowers LDL cholesterol (“bad cholesterol”)
Raises HDL cholesterol (“good cholesterol”)
Reduces triglycerides
Provides cardiovascular protection
Dosage Forms: Tablets (commonly 5 mg, 10 mg, 20 mg, 40 mg).
Common Brand Names: Crestor, Rosulip, Rozavel, Rosuva .
English:
Lowers “bad” cholesterol (LDL) and triglycerides
Raises “good” cholesterol (HDL)
Reduces risk of heart attack and stroke
Helps prevent narrowing of blood vessels
Safe for long-term use under medical supervision





